At ACT Advisors, we’re fortunate to support visionary leaders who dedicate their lives to solving some of the world’s most pressing challenges. One of those leaders is our client, Dr. Robert A. Harrington, whose most recent endeavor marks a pivotal moment in the fight against cancer.
A Bold Leap Forward: The Weill Cancer Research Center
In a powerful collaboration with philanthropists Sandy and Joan Weill, Dr. Harrington is helping launch a new, $160 million cancer research center focused on immunotherapy. This bold initiative—unveiled through Weill Cornell Medicine and New York-Presbyterian—aims to revolutionize how we understand and treat cancer by training the immune system to recognize and destroy cancer cells.
Watch the CNBC Exclusive interview here: Sandy Weill on the $50 million gift to establish new cancer hub, the promise of immunotherapy
Set to unite leading researchers, clinicians, and data scientists under one roof, the new Weill Center for Cancer Research will accelerate progress in immunotherapy, a cutting-edge approach that has already shown promise for many types of cancer.
As Dean of Weill Cornell Medicine and Provost for Medical Affairs at Cornell University, Dr. Harrington is playing a central role in the vision, strategy, and execution of this new center. His leadership ensures that this endeavor isn’t just about research—it’s about real-world impact for patients and families.
Cancer remains one of the most complex and devastating diseases of our time. Immunotherapy offers the potential not only to treat cancer more effectively but to personalize and precisely target treatments, reducing harmful side effects and improving long-term outcomes.
The launch of this center is more than just a philanthropic milestone. It’s a testament to what happens when innovative science, visionary leadership, and a deep commitment to human health come together.
While this new chapter in cancer research is headline-making, Dr. Harrington’s leadership is grounded in decades of excellence. Prior to his role at Weill Cornell, he chaired the Department of Medicine at Stanford University and led the Duke Clinical Research Institute—bringing his deep knowledge of clinical trials and collaborative science to every project.
His numerous accolades, including the American Heart Association’s highest honors and leadership roles on national medical committees, reflect a career built on evidence, ethics, and impact.
ACT Advisors: Standing Beside the Changemakers
At ACT Advisors, we don’t just manage wealth—we partner with individuals who are actively shaping the future. Dr. Harrington’s role in launching the Weill Center for Cancer Research embodies the kind of purpose-driven leadership that inspires us and aligns with our mission to protect and empower those who work for something bigger than themselves.
We’re proud to support Dr. Harrington in this transformative endeavor and can’t wait to see how this new cancer research hub accelerates breakthroughs for years to come.
ACT Advisors is a fee-only financial advisory firm based in Asheville, NC and Mt. Pleasant, SC. ACT Advisors specializes in providing personalized financial planning and investment management services, with a focus on helping credit union executives and professionals achieve their financial goals. As a fiduciary firm, ACT Advisors is committed to offering objective advice tailored to each client’s unique circumstances.